» Authors » Nisha Rajeswari Dhanushkodi

Nisha Rajeswari Dhanushkodi

Explore the profile of Nisha Rajeswari Dhanushkodi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 13
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zayou L, Prakash S, Vahed H, Dhanushkodi N, Quadiri A, Belmouden A, et al.
Front Immunol . 2025 Mar; 16:1503954. PMID: 40040708
Introduction: Since early 2020, several SARS-CoV-2 variants of concern (VOCs) continue to emerge, evading waning antibody mediated immunity produced by the current Spike-alone based COVID-19 vaccines. This caused a prolonged...
2.
Quadiri A, Prakash S, Zayou L, Dhanushkodi N, Chilukuri A, Ryan G, et al.
Vaccines (Basel) . 2025 Jan; 13(1). PMID: 39852826
Background: Nucleoside-modified mRNA encapsulated in lipid nanoparticles (LNPs) have emerged as a promising vaccine strategy, especially for COVID-19. While the LNPs protect mRNA from degradation and efficiently deliver the mRNA...
3.
Zayou L, Prakash S, Vahed H, Dhanushkodi N, Quadiri A, Belmouden A, et al.
bioRxiv . 2024 Oct; PMID: 39386567
Since early 2020, several SARS-CoV-2 variants of concern (VOCs) continue to emerge, evading waning antibody mediated immunity produced by the current Spike-alone based COVID-19 vaccines. This caused a prolonged and...
4.
Quadiri A, Prakash S, Dhanushkodi N, Singer M, Zayou L, Shaik A, et al.
J Virol . 2024 Apr; 98(5):e0159623. PMID: 38587378
Following acute herpes simplex virus type 2 (HSV-2) infection, the virus undergoes an asymptomatic latent infection of sensory neurons of dorsal root ganglia (DRG). Chemical and physical stress cause intermittent...
5.
Dhanushkodi N, Prakash S, Quadiri A, Zayou L, Srivastava R, Shaik A, et al.
J Immunol . 2024 Jan; 212(4):576-585. PMID: 38180084
SARS-CoV-2 variants of concern (VOCs) continue to evolve and reemerge with chronic inflammatory long COVID sequelae, necessitating the development of anti-inflammatory therapeutic molecules. Therapeutic effects of the receptor for advanced...
6.
Zayou L, Prakash S, Dhanushkodi N, Quadiri A, Ibraim I, Singer M, et al.
J Virol . 2023 Dec; 97(12):e0109623. PMID: 38038432
Although the current rate of SARS-CoV-2 infections has decreased significantly, COVID-19 still ranks very high as a cause of death worldwide. As of October 2023, the weekly mortality rate is...
7.
Quadiri A, Prakash S, Dhanushkodi N, Singer M, Zayou L, Shaik A, et al.
bioRxiv . 2023 Aug; PMID: 37609157
Following acute herpes simplex virus type 2 (HSV-2) infection, the virus undergoes latency in sensory neurons of the dorsal root ganglia (DRG). Intermittent virus reactivation from latency and shedding in...
8.
Dhanushkodi N, Prakash S, Quadiri A, Zayou L, Singer M, Takashi N, et al.
bioRxiv . 2023 Jun; PMID: 37292784
Vaginal mucosa-resident anti-viral effector memory B- and T cells appeared to play a crucial role in protection against genital herpes. However, how to mobilize such protective immune cells into the...
9.
Dhanushkodi N, Prakash S, Quadiri A, Zayou L, Srivastava R, Tran J, et al.
J Immunol . 2023 May; 211(1):118-129. PMID: 37222480
Four major mucosal-associated chemokines, CCL25, CCL28, CXCL14, and CXCL17, play an important role in protecting mucosal surfaces from infectious pathogens. However, their role in protection against genital herpes remains to...